Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Prevent Administration of Unnecessary Antihypertensive Medications

Bristol, Rhode Island Survey Completed on 06-05-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents' drug regimens were free from unnecessary drugs, specifically regarding the administration of antihypertensive medication. For one resident with a diagnosis of essential hypertension, a physician's order specified that Hydralazine 50 mg should be administered only if the systolic blood pressure (SBP) was greater than 160. However, medication administration records showed that the resident received Hydralazine multiple times when their SBP was below 160, with readings as low as 117. This was acknowledged by an LPN during a surveyor interview, confirming that the medication was given contrary to the physician's order. Another resident, also diagnosed with essential hypertension, had a physician's order for Hydralazine 25 mg every six hours, to be held if the SBP was less than 110. Despite this, records indicated that the medication was administered on several occasions when the resident's SBP was below 110, with readings as low as 88. This was similarly acknowledged by another LPN. The Director of Nursing Services was unable to provide evidence that these residents were free from unnecessary medications, as required.

An unhandled error has occurred. Reload 🗙